
Rheonix
Total Raised
$67.87MInvestors Count
10Deal Terms
2Funding, Valuation & Revenue
12 Fundings
Rheonix has raised $67.87M over 12 rounds.
Rheonix's latest funding round was a Loan for $1.5M on April 5, 2020.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
4/5/2020 | Loan | $1.5M | ||||
10/9/2015 | Series B - II | $28.6M | 2 | |||
4/13/2015 | Grant - V | $1.5M | 1 | |||
12/19/2013 | Series A - II | |||||
12/19/2013 | Debt |
Date | 4/5/2020 | 10/9/2015 | 4/13/2015 | 12/19/2013 | 12/19/2013 |
|---|---|---|---|---|---|
Round | Loan | Series B - II | Grant - V | Series A - II | Debt |
Amount | $1.5M | $28.6M | $1.5M | ||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 | 1 |
Rheonix Deal Terms
2 Deal Terms
Rheonix's deal structure is available for 2 funding rounds, including their Series B from February 14, 2012.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Rheonix Investors
10 Investors
Rheonix has 10 investors. Paycheck Protection Program invested in Rheonix's Loan funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/5/2020 | 4/5/2020 | 1 Loan | Government | DC | ||
1/16/2009 | 10/9/2015 | 4 Seed VC, Series A (2010), Series A - II (2013), Series B - II (2015) | Venture Capital | New York | ||
12/19/2013 | 10/9/2015 | 2 Series A - II, Series B - II (2015) | Asset/Investment Management | New York | ||
Venture Capital | Louisiana | |||||
Private Equity | New York |
First funding | 4/5/2020 | 1/16/2009 | 12/19/2013 | ||
|---|---|---|---|---|---|
Last Funding | 4/5/2020 | 10/9/2015 | 10/9/2015 | ||
Investor | |||||
Rounds | 1 Loan | 4 Seed VC, Series A (2010), Series A - II (2013), Series B - II (2015) | 2 Series A - II, Series B - II (2015) | ||
Board Seats | |||||
Type | Government | Venture Capital | Asset/Investment Management | Venture Capital | Private Equity |
Location | DC | New York | New York | Louisiana | New York |
Compare Rheonix to Competitors
Micromuscle offers polymer actuator technology for user friendly biomedical applications.
Biomedical Implant Technology Inc. is involved in the biomechanics of fixed dental prostheses and operates within the medical device manufacturing and engineering consulting sectors. The company provides products and services for dental implant solutions, including the manufacturing of fixed dental prostheses, such as screw retained and engaging metal ceramic restorations, along with consulting services for treatment planning and problem-solving in dental implantology. It is based in Blacksburg, Virginia.

Neuros Medical provides solutions for chronic pain management in the medical device industry. The company's main product, the Altius System, is an FDA-approved implanted electrical stimulation device designed to alleviate chronic post-amputation pain, such as phantom limb pain or residual limb pain, in adult amputees. The system allows patients to control their pain relief through a handheld remote, offering a non-addictive and non-toxic treatment option that aims to reduce or eliminate the need for opioids and improve the quality of life. It was founded in 2008 and is based in Aliso Viejo, California.
Leptos BioMedical is a company that operates in the online gaming and gambling industry, focusing on providing a variety of online slot games. The company offers a range of gaming services including high RTP (Return to Player) slots, progressive jackpots, and features such as free spins, catering to users interested in real money gaming. In addition to slots, Leptos BioMedical provides live casino games, sports betting, fishing games, lottery services, and poker rooms. It was founded in 2002 and is based in Fridley, Minnesota.
Celula is a diagnostic testing services company that specializes in diagnostic accuracy in the healthcare sector, specifically in prenatal and cancer diagnostics. The company provides prenatal testing solutions and methods for the early detection of ovarian cancer. Celula participates in research and development partnerships to improve women's health diagnostics. It was founded in 2005 and is based in San Diego, California.
Precision Light is a stealth-mode medical device company
Loading...

